1. Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden;
2. BGI-Shenzhen, Shenzhen, China;
3. Department of Biosciences and Nutrition, Karolinska Institutet, Solna, Sweden;
4. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands;
5. Department of Genetics, Portuguese Oncology Institute, and Abel Salazar Biomedical Sciences Institute, Porto University, Porto, Portugal;
6. Institute for Cancer Genetics, Columbia University, New York, NY;
7. State Key Laboratory of Oncology in South China and Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China;
8. Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China;
9. Department of Pathology and Cell Biology, Columbia University, New York, NY;
10. Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Solna, Sweden; and
11. Department of Immunology, Genetics and Pathology, Rudbecklaboratoriet, Uppsala University, Uppsala, Sweden